Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
- Status
- COMPLETED
- Phase
- PHASE3
An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME
- Status
- COMPLETED
- Phase
- PHASE3
A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE4
Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Tolerability of Combined Treatment With Nilotinib and Ruxolitinib in CML and Ph+ ALL Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa
- Status
- TERMINATED
- Phase
- PHASE4
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE4
Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor
- Status
- COMPLETED
- Phase
- PHASE3
A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374
- Status
- COMPLETED
- Phase
- PHASE1
Study of Afuresertib Combined With Paclitaxel in Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score
- Status
- TERMINATED
- Phase
- PHASE2
A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE4